AKT1 and cancer: Subsequently, to define the role of the PI3-K/Akt pathway in the antineoplastic drug resistance of cancer cells overexpressing HMGA1, we silenced Akt with a shRNA in GEO CR and FRO cells overexpressing HMGA1.